NPI: 1285627562 · WICHITA, KS 67206 · Optometrist · NPI assigned 08/23/2005
Authorized official GIRA, JOSEPH controls 20+ related entities in our dataset. Read more
| Authorized Official | GIRA, JOSEPH (CMO) |
| NPI Enumeration Date | 08/23/2005 |
Other providers sharing the same authorized official: GIRA, JOSEPH
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 60,887 | $1.36M |
| 2019 | 58,399 | $1.63M |
| 2020 | 44,217 | $1.23M |
| 2021 | 47,020 | $1.30M |
| 2022 | 17,090 | $479K |
| 2023 | 5,562 | $167K |
| 2024 | 4,070 | $129K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| V2020 | Frames, purchases | 55,542 | 50,649 | $2.00M |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 19,731 | 18,248 | $1.09M |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | 45,457 | 24,501 | $848K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 19,231 | 17,955 | $804K |
| 92015 | Determination of refractive state | 64,821 | 60,136 | $351K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 3,931 | 3,643 | $328K |
| V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | 6,966 | 4,126 | $146K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1,387 | 1,301 | $122K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3,582 | 3,351 | $116K |
| 67028 | Intravitreal injection of a pharmacologic agent | 2,406 | 1,942 | $92K |
| 92060 | 2,414 | 2,213 | $83K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1,128 | 1,046 | $73K |
| 92002 | 1,324 | 1,224 | $62K | |
| 92083 | 1,278 | 1,174 | $45K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 753 | 676 | $30K |
| V2203 | Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | 864 | 433 | $22K |
| 92134 | 2,934 | 2,550 | $17K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 228 | 142 | $17K |
| V2104 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 2.12 to 4.00d cylinder, per lens | 620 | 407 | $13K |
| 92250 | 663 | 577 | $12K | |
| 67311 | 12 | 12 | $6K | |
| 92235 | 124 | 103 | $3K | |
| J9035 | Injection, bevacizumab, 10 mg | 89 | 51 | $3K |
| 92136 | 129 | 108 | $2K | |
| J7999 | Compounded drug, not otherwise classified | 690 | 437 | $2K |
| V2107 | Spherocylinder, single vision, plus or minus 4.25 to plus or minus 7.00 sphere, .12 to 2.00d cylinder, per lens | 37 | 24 | $946.22 |
| V2782 | Lens, index 1.54 to 1.65 plastic or 1.60 to 1.79 glass, excludes polycarbonate, per lens | 904 | 447 | $165.00 |